We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

DOJ Probing Par Over Megace Off-Label Marketing

Law360 (March 30, 2009, 12:00 AM EDT) -- The U.S. Department of Justice has launched an investigation into Par Pharmaceutical Cos. Inc.'s promotional practices for its appetite enhancer Megace ES, the drugmaker said in a regulatory filing.

In a filing with the U.S. Securities and Exchange Commission on Friday, Par Pharmaceutical said the DOJ was investigating promotional practices in the sales and marketing of Megace ES, which is produced by Strativa Pharmaceuticals, a wholly owned and operated subsidiary of Par Pharmaceutical.

“We were served with a subpoena by the Department of Justice for documents...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.